English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907190      Online Users : 872
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11869


    Title: Activation of the CMV promoter: Considerations for viral vector-mediated transgene expression
    Authors: Howard, D;Back, S;Dossat, A;Chen, YH;Wang, Y;Harvey, BK
    Contributors: Center for Neuropsychiatric Research
    Abstract: The transcriptional promoter of the cytomegalovirus (CMV) immediate early genes has been extensively exploited in mammalian vectors used for in vitro and in vivo transgene delivery. Transcriptional activation by the CMV promoter is dependent on the presence of certain cellular transcription factors, several of which are known to be altered in response to cellular stimuli. However, the stability of transgene expression in model systems that depend on coincident stimuli has not previously been addressed. Here we monitored transgene expression from two different CMV-based promoters in AAV vectors targeting primary cortical neurons in vitro and rodent brain in vivo after they were treated with various stimulatory compounds or the activation of G-protein coupled receptors. Our results indicate that a general increase in neuronal activity, whether through excess of excitatory amino acids, activation of G protein-coupled signaling, or pharmacological stimulation of dopaminergic signaling can have a strong activating effects on the CMV promoter. These results have important implications for studies where stable constitutive expression of a transgene from the CMV promoter is assumed. Given these findings, caution should be applied when using the CMV promoter to drive expression of effectors of neuronal activation.
    Date: 2019-04
    Relation: Molecular Therapy. 2019 Apr;27(4, Suppl. 1):161.
    Link to: https://doi.org/10.1016/j.ymthe.2019.04.004
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1525-0016&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000464381002006
    Appears in Collections:[王昀] 會議論文/會議摘要

    Files in This Item:

    File SizeFormat
    ISI000464381002006.pdf35KbAdobe PDF278View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback